Publication | Open Access
LBA50 Perioperative nivolumab (NIVO) v placebo (PBO) in patients (pts) with resectable NSCLC: Clinical update from the phase III CheckMate 77T study
16
Citations
0
References
2024
Year
OncologyMedicineV PlaceboOutcomes ResearchPharmacotherapySurgeryPerioperative MedicinePerioperative CareClinical UpdateLba50 Perioperative NivolumabAnesthesiology
No additional data available for this publication yet. Check back later!